Consistent with our findings, n-3 PUFA has been reported to induce eNOS activation and NO-mediated coronary artery relaxation and improve endothelial dysfunction by regulating the imbalance between endothelium-derived factors through inhibition of NF-κB activity [39,40]. The gene discussed is NOS3; the disease is endothelial dysfunction.